Top Pharmaceutical Companies (2,035)
Smith's Food and Drug Centers, Inc., a subsidiary of The Kroger Company, is a supermarket chain operating throughout the Western United States. The company provides a comprehensive selection of grocery items across its locations, most of which also include an in-store pharmacy and bakery, offering customers a convenient one-stop shopping experience for their daily essentials.
Ferring Pharmaceuticals is a privately owned, research-driven, specialty biopharmaceutical group committed to building families and helping people live better lives. We are leaders in reproductive medicine and maternal health, and in areas of gastroenterology and urology. We are at the forefront of innovation in microbiome-based therapeutics and uro-oncology intravesical gene therapy. Ferring was founded in 1950 and employs more than...
Ferring Pharmaceuticals's Top Stability & Growth Strengths
Strong Revenue Growth: 2025 revenues exceeded €2.5 billion, rising versus 2024 with notable momentum in the U.S. and key contributions from Menopur and Adstiladrin. Company disclosures and the annual report indicate continued year-over-year top-line expansion.
Innovation-Driven Growth: First-in-class approvals (Rebyota in microbiome therapeutics and Adstiladrin in bladder-cancer gene therapy) and WHO-recognized maternal-health innovation (heat-stable carbetocin) demonstrate differentiated science translating into commercial progress. FDA clearance of a second U.S. Adstiladrin site supports scaling these innovations.
Strong Market Position & Advantage: Leadership in ART/fertility and first-mover status in microbiome therapeutics and intravesical gene therapy provide competitive advantages in defined niches. This positioning underpins recent growth in core franchises.
Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing lorundrostat, a proprietary oral aldosterone synthase inhibitor, to treat uncontrolled and resistant hypertension and related cardiorenal disorders (including CKD and OSA). The company focuses on targeted therapies for diseases driven by dysregulated aldosterone and is advancing late-stage clinical programs and regulatory filings to bring this treatment to patients.
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development...
ICON plc's Top Stability & Growth Strengths
Strong Market Position & Advantage: The company is positioned as a top-tier global CRO with significant scale and a broad geographic footprint, supported by a major acquisition that strengthened its competitive standing. Operational activity indicators and industry recognition are presented as reinforcing its ability to win and execute large, complex trials.
Profitability: Earnings and operating profit metrics are described as improving in 2024, with increases in GAAP net income, adjusted earnings per share, and adjusted EBITDA. These results suggest the business maintained solid margin performance even as quarterly revenue fluctuated.
Resilient & Sustainable Growth: A large backlog and a book-to-bill above 1.0 in 2024 are cited as providing multi-year revenue visibility and demand coverage. Continued backlog levels into 2025 are described as a stabilizing factor despite a softer near-term revenue trajectory.
American Oncology Network, Inc. (AON) is a rapidly growing network of community-based oncology practices in the United States. AON provides comprehensive oncology management services, including specialty pharmacy, laboratory services, and care management support. By acting as an alliance of physicians and healthcare leaders, AON empowers community oncologists to deliver high-quality cancer care and improve patient outcomes through integrated services and...
Delphon Industries is a global provider of engineered polymer and adhesive products specializing in high-end material solutions for the semiconductor, photonics, medical, and electronics industries. Founded in 1982, the company develops device protection and adhesive solutions through its brands Gel-Pak, TouchMark, and UltraTape, serving over 2,500 customers worldwide with highly engineered materials and advanced manufacturing technologies.
Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on...
AstraZeneca is a global, science-led, patient-focused biopharmaceutical company committed to excellence in the research, development, and commercialization of prescription medicines. With approximately 90,000 employees across 85 countries, the company aims to unlock the power of science to deliver innovative medicines that transform patient outcomes and improve healthcare for people, society, and the planet worldwide.
Norgine is a leading European specialist pharmaceutical company that has been bringing transformative medicines to patients for over a century. Our commitment to transforming people’s lives drives everything we do and our European experience, fully integrated infrastructure and exceptional partnership approach enables us to quickly apply creative solutions to bring life-changing medicines to patients that they may not otherwise be...
Frontage Laboratories, Inc. is a CRO that provides integrated, science-driven, product development services throughout the drug discovery and development process to enable pharmaceutical and biotechnology companies to achieve their development goals. Comprehensive services include drug metabolism and pharmacokinetics, analytical testing and formulation development, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safety and toxicology assessment and early phase clinical studies....
Frontage Laboratories, Inc's Top Stability & Growth Strengths
Market Expansion: Recent announcements describe expansion of early‑phase clinical capabilities in 2026 alongside new and enlarged sites in Exton, Pennsylvania and Europe, indicating broader geographic reach and capacity. Acquisitions and a rising backlog/future contracted revenue further point to continuing expansion into additional markets and regions.
Product Line Growth: New GMP CRDMO capacity came online with a 46,300‑sq‑ft facility opened in 2025 and fully validated by late 2025, adding nine GMP suites and related labs. The 2026 acquisition of a CAP‑accredited central lab in China and added early‑phase clinical capabilities broaden the service portfolio.
Strong Revenue Growth: Recent interim results show first‑half 2026 revenue up 17.1% year over year with net profit more than doubling, signaling a rebound from prior softness. Purchase orders/backlog also increased versus prior periods, supporting near‑term top‑line momentum.
Emmaus Life Sciences, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of innovative treatments and therapies primarily for rare and orphan diseases.
Through advancing research, observing natural behavior, and listening to our customers, Medela turns science into care while nurturing health for generations. Medela supports millions of moms, babies, patients, and healthcare professionals in more than 100 countries all over the world. As the healthcare choice for more than 6 million hospitals and homes across the globe, Medela provides the leading research-based breast...
RedSail Technologies, LLC, is empowering pharmacy and transforming care with a network of over 11,500+ pharmacies serving more than 8 million patients monthly. RedSail has deep experience across sectors – community, long-term care, outpatient, clinic, HME/DME, and specialty pharmacies – and their pharma, payer, and strategic industry partners. PioneerRx® is RedSail’s industry-leading pharmacy management system for independent/retail pharmacy. Axys® is...
RedSail Technologies's Top Stability & Growth Strengths
Strong Market Position & Advantage: Scale in independent/community pharmacy is described as market‑leading after a string of acquisitions and integrations, with a network of roughly 16,000 U.S. pharmacies using RedSail platforms. Breadth across brands (PioneerRx, QS/1/PrimeCare, BestRx, PrimeRx, Axys LTC) reinforces standing within community and LTC segments.
Product Line Growth: The portfolio has expanded beyond core PMS into payments (RedSail Pay via Emporos), marketplace (RxMarket), delivery (RxMile), medical billing (TransactRx), and claims switching (PowerLine). These additions broaden the stack for independents and LTC and increase cross‑sell potential.
Investor Backing & Capital Strength: A strategic growth investment from Leonard Green & Partners in June 2024, with Francisco Partners reinvesting, signals balance‑sheet support for continued M&A and product build‑out. Ongoing activity—such as the PrimeRx acquisition in February 2026—aligns with this capital‑backed growth thesis.
XVET GmbH is a global supplier and GMP+ certified exporter of natural, science-based feed and drinking water additives for animal rearing. Founded in 2002, the company is dedicated to supporting sustainable agriculture and advancing animal welfare, especially within the poultry industry. By providing innovative, antibiotic-reducing solutions, XVET helps producers achieve healthier livestock and higher production quality through a diverse range...
Sharp Services is a global leader in pharmaceutical CDMO services, specializing in commercial packaging, clinical trial services, and sterile manufacturing. They partner with pharmaceutical and biopharmaceutical clients, offering comprehensive solutions and support from phase I trials through to commercial launch and lifecycle management to help bring important medicines to patients worldwide.
SynX Therapeutics is a pre-seed biotech start-up focused on building the world's fastest lab-in-the-loop platform for drug discovery. They leverage engineered biology, high-throughput experimentation, and AI to enable the ultra-rapid discovery and optimization of non-natural macrocyclic peptide therapeutics.
iNova Pharmaceuticals is leading the way to better health by constantly searching for new, practical solutions that improve the everyday health and wellbeing of people around the world. Our portfolio of market-leading consumer health brands and prescription medicines are backed by science and span across the key therapeutic areas of throat, cough, cold & flu, skin care, sun care, pain management,...
Veterinary Service Inc. is a leading distributor of animal health products, servicing thousands of customers across the western United States. With eight strategic locations and access to over 500 vendors, the company provides comprehensive solutions for all animal health product needs, supporting beef producers and livestock organizations throughout the country with an unwavering commitment to customer focus since 1960.
U.S. Dermatology Partners is one of the largest physician-owned dermatology practices in the United States, providing premier medical, surgical, and cosmetic skin care to over two million patients annually. With more than 130 locations across nine states, the organization focuses on patient-first care, combining the personalized experience of private practice with a coordinated network of specialized physicians and national thought...
Orakl Oncology is a techbio startup and precision oncology company that combines cutting-edge biology and AI to accelerate cancer drug discovery and development. Utilizing an innovative predictive engine and one of the world's largest collections of patient tumor avatars, the company aims to de-risk clinical trials, identify new drug targets, and expand the therapeutic arsenal available to cancer patients.
